Global and Japan Antibody Humanization Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Humanization Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Monoclonal Antibodies
1.2.3 Bispecific Antibodies
1.2.4 CDR Grafted Antibodies
1.3 Market by Application
1.3.1 Global Antibody Humanization Market Share by Application: 2020 VS 2026
1.3.2 HIV
1.3.3 SARS
1.3.4 RSV
1.3.5 Prion
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Antibody Humanization Market Perspective (2015-2026)
2.2 Global Antibody Humanization Growth Trends by Regions
2.2.1 Antibody Humanization Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Antibody Humanization Historic Market Share by Regions (2015-2020)
2.2.3 Antibody Humanization Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Humanization Players by Market Size
3.1.1 Global Top Antibody Humanization Players by Revenue (2015-2020)
3.1.2 Global Antibody Humanization Revenue Market Share by Players (2015-2020)
3.2 Global Antibody Humanization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antibody Humanization Revenue
3.4 Global Antibody Humanization Market Concentration Ratio
3.4.1 Global Antibody Humanization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Humanization Revenue in 2019
3.5 Key Players Antibody Humanization Area Served
3.6 Key Players Antibody Humanization Product Solution and Service
3.7 Date of Enter into Antibody Humanization Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Humanization Breakdown Data by Type (2015-2026)
4.1 Global Antibody Humanization Historic Market Size by Type (2015-2020)
4.2 Global Antibody Humanization Forecasted Market Size by Type (2021-2026)
5 Antibody Humanization Breakdown Data by Application (2015-2026)
5.1 Global Antibody Humanization Historic Market Size by Application (2015-2020)
5.2 Global Antibody Humanization Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Antibody Humanization Market Size (2015-2026)
6.2 North America Antibody Humanization Market Size by Type (2015-2020)
6.3 North America Antibody Humanization Market Size by Application (2015-2020)
6.4 North America Antibody Humanization Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Antibody Humanization Market Size (2015-2026)
7.2 Europe Antibody Humanization Market Size by Type (2015-2020)
7.3 Europe Antibody Humanization Market Size by Application (2015-2020)
7.4 Europe Antibody Humanization Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Antibody Humanization Market Size (2015-2026)
8.2 China Antibody Humanization Market Size by Type (2015-2020)
8.3 China Antibody Humanization Market Size by Application (2015-2020)
8.4 China Antibody Humanization Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Antibody Humanization Market Size (2015-2026)
9.2 Japan Antibody Humanization Market Size by Type (2015-2020)
9.3 Japan Antibody Humanization Market Size by Application (2015-2020)
9.4 Japan Antibody Humanization Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Antibody Humanization Market Size (2015-2026)
10.2 Southeast Asia Antibody Humanization Market Size by Type (2015-2020)
10.3 Southeast Asia Antibody Humanization Market Size by Application (2015-2020)
10.4 Southeast Asia Antibody Humanization Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Accurus Biosciences
11.1.1 Accurus Biosciences Company Details
11.1.2 Accurus Biosciences Business Overview
11.1.3 Accurus Biosciences Antibody Humanization Introduction
11.1.4 Accurus Biosciences Revenue in Antibody Humanization Business (2015-2020))
11.1.5 Accurus Biosciences Recent Development
11.2 IONTAS
11.2.1 IONTAS Company Details
11.2.2 IONTAS Business Overview
11.2.3 IONTAS Antibody Humanization Introduction
11.2.4 IONTAS Revenue in Antibody Humanization Business (2015-2020)
11.2.5 IONTAS Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Antibody Humanization Introduction
11.3.4 Lonza Revenue in Antibody Humanization Business (2015-2020)
11.3.5 Lonza Recent Development
11.4 Oak BioSciences
11.4.1 Oak BioSciences Company Details
11.4.2 Oak BioSciences Business Overview
11.4.3 Oak BioSciences Antibody Humanization Introduction
11.4.4 Oak BioSciences Revenue in Antibody Humanization Business (2015-2020)
11.4.5 Oak BioSciences Recent Development
11.5 Panorama Research
11.5.1 Panorama Research Company Details
11.5.2 Panorama Research Business Overview
11.5.3 Panorama Research Antibody Humanization Introduction
11.5.4 Panorama Research Revenue in Antibody Humanization Business (2015-2020)
11.5.5 Panorama Research Recent Development
11.6 PX'Therapeutics
11.6.1 PX'Therapeutics Company Details
11.6.2 PX'Therapeutics Business Overview
11.6.3 PX'Therapeutics Antibody Humanization Introduction
11.6.4 PX'Therapeutics Revenue in Antibody Humanization Business (2015-2020)
11.6.5 PX'Therapeutics Recent Development
11.7 Yurogen Biosystems
11.7.1 Yurogen Biosystems Company Details
11.7.2 Yurogen Biosystems Business Overview
11.7.3 Yurogen Biosystems Antibody Humanization Introduction
11.7.4 Yurogen Biosystems Revenue in Antibody Humanization Business (2015-2020)
11.7.5 Yurogen Biosystems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Antibody Humanization Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Monoclonal Antibodies
Table 4. Key Players of Bispecific Antibodies
Table 5. Key Players of CDR Grafted Antibodies
Table 6. Global Antibody Humanization Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Antibody Humanization Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Antibody Humanization Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Antibody Humanization Market Share by Regions (2015-2020)
Table 10. Global Antibody Humanization Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Antibody Humanization Market Share by Regions (2021-2026)
Table 12. Antibody Humanization Market Market Trends
Table 13. Antibody Humanization Market Drivers
Table 14. Antibody Humanization Market Challenges
Table 15. Antibody Humanization Market Restraints
Table 16. Global Antibody Humanization Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Antibody Humanization Market Share by Players (2015-2020)
Table 18. Global Top Antibody Humanization Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Humanization as of 2019)
Table 19. Global Antibody Humanization by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antibody Humanization Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antibody Humanization Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Antibody Humanization Market Size Share by Type (2015-2020)
Table 25. Global Antibody Humanization Revenue Market Share by Type (2021-2026)
Table 26. Global Antibody Humanization Market Size Share by Application (2015-2020)
Table 27. Global Antibody Humanization Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Antibody Humanization Market Size Share by Application (2021-2026)
Table 29. North America Antibody Humanization Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Antibody Humanization Market Share by Type (2015-2020)
Table 31. North America Antibody Humanization Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Antibody Humanization Market Share by Application (2015-2020)
Table 33. North America Antibody Humanization Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Antibody Humanization Market Share by Country (2015-2020)
Table 35. Europe Antibody Humanization Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Antibody Humanization Market Share by Type (2015-2020)
Table 37. Europe Antibody Humanization Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Antibody Humanization Market Share by Application (2015-2020)
Table 39. Europe Antibody Humanization Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Antibody Humanization Market Share by Country (2015-2020)
Table 41. China Antibody Humanization Market Size by Type (2015-2020) (US$ Million)
Table 42. China Antibody Humanization Market Share by Type (2015-2020)
Table 43. China Antibody Humanization Market Size by Application (2015-2020) (US$ Million)
Table 44. China Antibody Humanization Market Share by Application (2015-2020)
Table 45. China Antibody Humanization Market Size by Region (US$ Million) (2015-2020)
Table 46. China Antibody Humanization Market Share by Region (2015-2020)
Table 47. Japan Antibody Humanization Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Antibody Humanization Market Share by Type (2015-2020)
Table 49. Japan Antibody Humanization Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Antibody Humanization Market Share by Application (2015-2020)
Table 51. Japan Antibody Humanization Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Antibody Humanization Market Share by Country (2015-2020)
Table 53. Southeast Asia Antibody Humanization Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Antibody Humanization Market Share by Type (2015-2020)
Table 55. Southeast Asia Antibody Humanization Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Antibody Humanization Market Share by Application (2015-2020)
Table 57. Southeast Asia Antibody Humanization Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Antibody Humanization Market Share by Country (2015-2020)
Table 59. Accurus Biosciences Company Details
Table 60. Accurus Biosciences Business Overview
Table 61. Accurus Biosciences Product
Table 62. Accurus Biosciences Revenue in Antibody Humanization Business (2015-2020) (US$ Million)
Table 63. Accurus Biosciences Recent Development
Table 64. IONTAS Company Details
Table 65. IONTAS Business Overview
Table 66. IONTAS Product
Table 67. IONTAS Revenue in Antibody Humanization Business (2015-2020) (US$ Million)
Table 68. IONTAS Recent Development
Table 69. Lonza Company Details
Table 70. Lonza Business Overview
Table 71. Lonza Product
Table 72. Lonza Revenue in Antibody Humanization Business (2015-2020) (US$ Million)
Table 73. Lonza Recent Development
Table 74. Oak BioSciences Company Details
Table 75. Oak BioSciences Business Overview
Table 76. Oak BioSciences Product
Table 77. Oak BioSciences Revenue in Antibody Humanization Business (2015-2020) (US$ Million)
Table 78. Oak BioSciences Recent Development
Table 79. Panorama Research Company Details
Table 80. Panorama Research Business Overview
Table 81. Panorama Research Product
Table 82. Panorama Research Revenue in Antibody Humanization Business (2015-2020) (US$ Million)
Table 83. Panorama Research Recent Development
Table 84. PX'Therapeutics Company Details
Table 85. PX'Therapeutics Business Overview
Table 86. PX'Therapeutics Product
Table 87. PX'Therapeutics Revenue in Antibody Humanization Business (2015-2020) (US$ Million)
Table 88. PX'Therapeutics Recent Development
Table 89. Yurogen Biosystems Company Details
Table 90. Yurogen Biosystems Business Overview
Table 91. Yurogen Biosystems Product
Table 92. Yurogen Biosystems Revenue in Antibody Humanization Business (2015-2020) (US$ Million)
Table 93. Yurogen Biosystems Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Antibody Humanization Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Bispecific Antibodies Features
Figure 4. CDR Grafted Antibodies Features
Figure 5. Global Antibody Humanization Market Share by Application: 2020 VS 2026
Figure 6. HIV Case Studies
Figure 7. SARS Case Studies
Figure 8. RSV Case Studies
Figure 9. Prion Case Studies
Figure 10. Antibody Humanization Report Years Considered
Figure 11. Global Antibody Humanization Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Antibody Humanization Market Share by Regions: 2020 VS 2026
Figure 13. Global Antibody Humanization Market Share by Regions (2021-2026)
Figure 14. Global Antibody Humanization Market Share by Players in 2019
Figure 15. Global Top Antibody Humanization Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Humanization as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Antibody Humanization Revenue in 2019
Figure 17. North America Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Antibody Humanization Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Accurus Biosciences Revenue Growth Rate in Antibody Humanization Business (2015-2020)
Figure 45. IONTAS Revenue Growth Rate in Antibody Humanization Business (2015-2020)
Figure 46. Lonza Revenue Growth Rate in Antibody Humanization Business (2015-2020)
Figure 47. Oak BioSciences Revenue Growth Rate in Antibody Humanization Business (2015-2020)
Figure 48. Panorama Research Revenue Growth Rate in Antibody Humanization Business (2015-2020)
Figure 49. PX'Therapeutics Revenue Growth Rate in Antibody Humanization Business (2015-2020)
Figure 50. Yurogen Biosystems Revenue Growth Rate in Antibody Humanization Business (2015-2020)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed